Category: Hematology & Oncology
Europe Hematology & Oncology
-
2022-2026 Global Cancer Diagnostics Market Opportunities for Major Tumor Markers: USA, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging ... Read More
-
2022-2026 Italy Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... study of the major business opportunities emerging in the Italian cancer diagnostics market during the next five years. The report examines trends in the Italian cancer diagnostics markets, reviews current and emerging assays; analyzes potential ... Read More
-
2022-2026 France Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets, reviews current and emerging assays; analyzes potential ... Read More
-
2022-2026 Europe Cancer Diagnostics Market Opportunities for Major Tumor Markers for Major Tumor Markers: A 38-Country Analysis - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... for Suppliers This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into ... Read More
-
2022-2026 Germany Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... study of the major business opportunities emerging in the German cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets, reviews current and emerging assays; analyzes potential ... Read More
-
2022-2026 Europe Cancer Diagnostics Market Opportunities for Major Tumor Markers: France, Germany, Italy, Spain, UK - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com's new report is a study of the major business opportunities emerging in the European cancer diagnostics market during the next five years. The report examines trends in major European countries; reviews current and emerging ... Read More
-
2022-2026 UK Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... study of the major business opportunities emerging in the UK cancer diagnostics market during the next five years. The report examines trends in the UK cancer diagnostics markets, reviews current and emerging assays; analyzes potential ... Read More
-
The Worldwide Market for Liquid Biopsy (by Analyte [ctDNA, cfDNA, Other], by Application - Screening/Drug Monitoring/Diagnostic, by Region [US, Europe, Asia, ROW] and by Type of Cancer)
... and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed. Companies covered Include: cfDNA-based Liquid Biopsy Adaptive Biotechnologies Biodesix Epigenomics ... Read More